Rikiya Taoka
- Urology top 5%
- Urological Disorders and Treatments 11
- Urinary Bladder and Prostate Research 5
-
- Prostate Cancer Diagnosis and Treatment 16
- Prostate Cancer Treatment and Research 11
-
- Bladder and Urothelial Cancer Treatments 30
- Urinary and Genital Oncology Studies 18
-
- Epigenetics and DNA Methylation 5
-
- Urinary Tract Infections Management 5
- Co-authors
- Yoshiyuki KakehiMikio SugimotoHiroyuki TsunemoriReiji HabaAshish M. KamatMasashi IshikawaGoodwin G. JineshYuki Matsuoka
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)International Journal of Molecular Sciences (2 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Rikiya Taoka
62 papers receiving 549 citations
Peers
Comparison fields: 5 of 78
- Urology 106
- Pulmonary and Respiratory Medicine 256
- Cancer Research 65
- Surgery 182
- Rheumatology 55
Countries citing papers authored by Rikiya Taoka
This map shows the geographic impact of Rikiya Taoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikiya Taoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikiya Taoka more than expected).
Fields of papers citing papers by Rikiya Taoka
This network shows the impact of papers produced by Rikiya Taoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikiya Taoka. The network helps show where Rikiya Taoka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rikiya Taoka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 18 | |
| 16 | 2022 | 1 | |
| 17 | 2022 | 3 | |
| 18 | 2021 | 1 | |
| 19 | 2019 | 3 | |
| 20 | 2018 | 7 |
About Rikiya Taoka
Rikiya Taoka is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 557 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (30 papers), Urinary and Genital Oncology Studies (18 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Urological Disorders and Treatments (11 papers), Prostate Cancer Treatment and Research (11 papers), Urinary Bladder and Prostate Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Urology (106 citations), Pulmonary and Respiratory Medicine (256 citations) and Cancer Research (65 citations). Rikiya Taoka has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoshiyuki Kakehi, Mikio Sugimoto, Hiroyuki Tsunemori, Reiji Haba, Ashish M. Kamat, Masashi Ishikawa, Goodwin G. Jinesh, Yuki Matsuoka, Nobufumi Ueda and Yoichiro Tohi. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.